Asia-Pacific Drugs of Abuse Testing Devices Market Insights, Forecast to 2028

Asia-Pacific Drugs of Abuse Testing Devices Market Insights, Forecast to 2028

Summary

Market Analysis and Insights: Asia-Pacific Drugs of Abuse Testing Devices Market
The Asia-Pacific Drugs of Abuse Testing Devices market is valued at US$ 194.88 million in 2022. The market size will reach US$ 316.77 million by the end of 2028, growing at a CAGR of 8.43% during 2022-2028.
Asia-Pacific Drugs of Abuse Testing Devices Scope and Segment
Drugs of Abuse Testing Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the Asia-Pacific Drugs of Abuse Testing Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.
By Company
Abbott
Thermo Fisher
Roche
Siemens Healthineers
Wondfo Biotech
Randox
OraSure
Draeger
InTec
Orient Gene
Hangzhou Biotest
Assure Tech
Aotai Bio

Segment by Type
Urine Testing
Saliva Testing
Blood Testing
Hair and Sweat Testing
Others

Segment by Application
Hospital
Law Enforcement
Drug Treatment Center
Laboratory
Others

Segment by Region/Country
China
Japan
South Korea
India
China Taiwan
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Singapore
Other Regions